Efficacy and safety of molnupiravir for COVID-19 patients.

Fatima, Maurish; Azeem, Saleha; Saeed, Junaid; Shahid, Abia; Cheema, Huzaifa Ahmad

Fatima, Maurish; Azeem, Saleha; Saeed, Junaid; Shahid, Abia; Cheema, Huzaifa Ahmad.

Afiliación

Fatima M; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Azeem S; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Saeed J; Department of Medicine, Nishtar Medical University, Lahore, Pakistan.
Shahid A; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Cheema HA; Department of Medicine, King Edward Medical University, Lahore, Pakistan. Electronic address: huzaifacheema@kemu.edu.pk.

Eur J Intern Med ; 102: 118-121, 2022 08.

Article en En | MEDLINE | ID: mdl-35649740

Asunto(s)

COVID-19; Antivirales/efectos adversos; Citidina/análogos & derivados; Humanos; Hidroxilaminas

Palabras clave

COVID-19; EIDD-2801; MK-4482; Meta-analysis; Molnupiravir; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Eur J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: Pakistán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google